Jenny Bryant serves as Senior Vice President, Policy and Research for the Pharmaceutical Research and Manufacturers of America (PhRMA), the national association representing the country’s leading pharmaceutical research and biotechnology companies.
At PhRMA, she oversees analysis and development of public policy related to health care costs and spending, prescription drug pricing, and changes in health care delivery and payment. She manages a broad portfolio of economic and policy research, with a focus on better understanding how medicines are used and valued, and the impact of appropriate medication use on health care costs.
Prior to joining PhRMA, Ms. Bryant was Vice President at The Lewin Group, a national health care consulting firm. Previously, she held positions at Blue Cross Blue Shield Association, Blue Cross Blue Shield of Florida, New York Hospital-Cornell Medical Center, and the State of New York.
Ms. Bryant graduated magna cum laude from Harvard College and received her MBA from the Harvard Graduate School of Business Administration.